WHO ICTRP trial
unani formulation for menstrual irregularity associated with polycystic ovaries
CTRI/2025/02/080246 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/02/080246 |
|---|---|
| Public title | unani formulation for menstrual irregularity associated with polycystic ovaries |
| Scientific title | Efficacy of Asgand and Khare khasak in polycystic ovarian syndrome- A Pilot Study |
| Primary sponsor | Admn block st floor National Institute of Unani Medicine |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: E282- Polycystic ovarian syndrome |
| Interventions | Intervention1: Asgand (Withania somnifera Dunal) and Khare khasak (Tribulus terrestris Linn): 7 gms twice daily from 5th day of cycle for 21 days. Control Intervention1: Nil: Nil |
| Registration date | Oct 2, 2025 |
| Target size | 30 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: